COMBINEDBRAIN HNF

CMT Biobank: We Need Your HELP!

by | Feb 1, 2024 | 0 comments

CMT Biobank: We Need Your HELP!

HNF is excited to continue collecting samples for researchers and industry to help develop treatments for CMT. CMT impacts the quality of life starting in childhood and is progressively debilitating. Currently, there are no treatments, but there are many potential therapies in the pipeline. There are still gaps in understanding the natural history of the disease correlation of genotype/ phenotype, the availability of patient biospecimens for translational research, and the validation of drug candidates and biomarkers for CMT.

HNF is the only CMT advocacy group that gives access to these patient samples at minimal cost.

The locations for specimen collection are currently being discussed. Please give us feedback if you would like us to come to a city near you!

Learn more on this topic

Related Blog Posts

HNF-WVU-NIOSH Study update:

We are pleased to update our readers on the progress of the WVU-NIOSH study, “A Bi-Directional Translational Model of Exercise Training in the Treatment of Charcot-Marie-Tooth Disease”

Dr. Robert Baloh Answers Our Questions About iPS Cell Research

Big news is happening on a cellular level at Cedars-Sinai Medical Center’s Regenerative Medicine Institute in Los Angeles, CA.  Robert H. Baloh, MD PhD, Director of Neuromuscular Medicine, in conjunction with Patrick D. Lyden, MD Neurology Dept. Chair, and Clive Svendsen, PhD, Institute Director, are studying disorders that start in nerve cells. 

Join the conversation

Leave a Comment

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

Newsletter

Join for notifications on events, campaigns, & news